HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gi-Hoon Nam Selected Research

Therapeutic Uses

4/2024Novel Personalized Cancer Vaccine Using Tumor Extracellular Vesicles with Attenuated Tumorigenicity and Enhanced Immunogenicity.
10/2021The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gi-Hoon Nam Research Topics

Disease

25Neoplasms (Cancer)
04/2024 - 01/2017
3Melanoma (Melanoma, Malignant)
01/2021 - 10/2017
1COVID-19
01/2023
1Communicable Diseases (Infectious Diseases)
01/2023
1Anemia
11/2022
1Thrombocytopenia (Thrombopenia)
11/2022
1Squamous Cell Carcinoma of Head and Neck
12/2021
1Uveal melanoma
01/2021
1Neoplasm Metastasis (Metastasis)
01/2021
1Colorectal Neoplasms (Colorectal Cancer)
01/2021
1Carcinogenesis
10/2017
1Stomatitis
04/2017

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2017
4Immune Checkpoint InhibitorsIBA
10/2021 - 01/2021
3Doxorubicin (Adriamycin)FDA LinkGeneric
11/2022 - 01/2021
3Peptides (Polypeptides)IBA
01/2021 - 12/2017
2Neoplasm Antigens (Tumor Antigens)IBA
04/2024 - 01/2020
2Therapeutic UsesIBA
04/2024 - 10/2021
2AntigensIBA
01/2023 - 11/2019
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2021 - 01/2021
2LigandsIBA
10/2021 - 03/2018
2Apoptosis Regulatory ProteinsIBA
10/2021 - 10/2017
2rho-Associated KinasesIBA
01/2021 - 01/2018
2Membrane Proteins (Integral Membrane Proteins)IBA
12/2020 - 04/2017
2Ferritins (Ferritin)IBA
10/2018 - 12/2017
1VaccinesIBA
04/2024
1Cancer VaccinesIBA
04/2024
1NucleolinIBA
01/2023
1AntibodiesIBA
11/2022
1Programmed Cell Death 1 ReceptorIBA
12/2021
1Cisplatin (Platino)FDA LinkGeneric
12/2021
1CalreticulinIBA
12/2021
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
10/2021
1TNF-Related Apoptosis-Inducing LigandIBA
10/2021
1Antineoplastic Agents (Antineoplastics)IBA
10/2021
1Biomarkers (Surrogate Marker)IBA
10/2021
1ProdrugsIBA
01/2021
1farnesyl pyrophosphate (farnesyl diphosphate)IBA
01/2021
11-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2021
1phenylalanyl-arginyl-arginineIBA
01/2021
1K-115IBA
01/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021
1Cathepsin BIBA
01/2021
1geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA
01/2021
1Terpenes (Terpenoids)IBA
01/2021
1MicroRNAs (MicroRNA)IBA
12/2020
1Nucleic AcidsIBA
10/2020
1monophosphoryl lipid AIBA
01/2020
1Viral AntigensIBA
01/2020
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2019
1Coloring Agents (Dyes)IBA
01/2019
1ErbB Receptors (EGF Receptor)IBA
12/2017
1Inosine Diphosphate (IDP)IBA
12/2017
1Intrinsically Disordered ProteinsIBA
12/2017
1Small Interfering RNA (siRNA)IBA
10/2017
1Dermatan SulfateIBA
10/2017
1InterferonsIBA
10/2017
1PolyethyleneimineIBA
10/2017
1DisulfidesIBA
10/2017
1GTP-Binding Proteins (G-Protein)IBA
04/2017

Therapy/Procedure

14Immunotherapy
04/2024 - 01/2018
11Therapeutics
12/2021 - 01/2017
1Ligation
11/2022
1Photochemotherapy (Photodynamic Therapy)
01/2021
1Cell- and Tissue-Based Therapy (Cell Therapy)
11/2019